CE Mark for IOL and delivery system

Article

Abbott Medical Optics (AMO) has announced the launch and CE Mark of approval for both the Tecnis multifocal toric IOL and iTec preloaded delivery system at the ESCRS in Milan this year.

Abbott Medical Optics (AMO) has announced the launch and CE Mark of approval for both the Tecnis multifocal toric IOL and iTec preloaded delivery system at the ESCRS in Milan this year.

The IOL is a premium lens solution for astigmatic cataract patients and provides spectacle-independence for the patient. It can also correct presbyopia and corneal astigmatism.

AMO also introduced the iTec preloaded delivery system, which allows the safe implantation of the IOL without having to manually load the lens. The delivery system is a highly-controlled, screw-style device providing reliability and efficiency for the surgeon.

Jim Mazzo, senior vice president of AMO, stated, "Cataract surgeons in Europe now have two new products available to address the unique lifestyle needs of their patients, By receiving CE Mark for the TECNIS Multifocal Toric IOL and the TECNIS iTec Preloaded Delivery System, Abbott continues to demonstrate its commitment to advancing cataract vision care innovation and providing high quality patient outcomes."

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.